| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/17/2006 | US20060183732 Novel lactams and uses thereof |
| 08/17/2006 | US20060183731 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 08/17/2006 | US20060183730 Novel carbapenem compounds |
| 08/17/2006 | US20060183729 Vanadium compounds as anti-angiogenic agents |
| 08/17/2006 | US20060183728 Combination chemotherapy compositions and methods |
| 08/17/2006 | US20060183727 Estrogenic compounds as anti-mitotic agents |
| 08/17/2006 | US20060183726 Pharmaceutical compositions based on anticholinergics and etiprednol |
| 08/17/2006 | US20060183725 Pharmaceutical preparation for oral contraception |
| 08/17/2006 | US20060183724 Compositions of unconjugated estrogens and methods for their use |
| 08/17/2006 | US20060183723 Ethercarboxylic acid ester of sterol or stanol |
| 08/17/2006 | US20060183722 Formulation for lipophilic agents |
| 08/17/2006 | US20060183721 2-Methylene-19-nor-(20S-24epi)-1alpha,25-dihydroxyvitamin D2 |
| 08/17/2006 | US20060183720 such as (4S,4aS,5aR,12aS)-9-[(N-cyclohexyl-N-hydroxyglycyl)amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, useful as antimicrobial agents and exhibit antibacterial activity against a wide spectrum of microorganisms |
| 08/17/2006 | US20060183719 Tetracycline metal complex in a solid dosage form |
| 08/17/2006 | US20060183718 Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof |
| 08/17/2006 | US20060183717 Process for treating lameness with an osseous, articular or osteoarticular component in human or veterinary medicine, comprising the administration of a bisphosphonic acid derivative |
| 08/17/2006 | US20060183716 High binding to vitamin D receptors; intestinal calcium transport activity; psoriasis; leukemia; anticarcinogenic agents; multiple sclerosis; lupus; antidiabetic agents; host versus graft/organ reaction; antiinflammatory agents; rheumatoid arthritis; asthma; inflammatory bowel disease; skin/bone disorder |
| 08/17/2006 | US20060183715 Sulfated fucoglucuronomannan |
| 08/17/2006 | US20060183714 3-Alpha-glycosyl alpha, alpha-trehalose compound, process for producing the same, and use |
| 08/17/2006 | US20060183713 Compositions of low molecular weight heparin produced with modified heparinase III |
| 08/17/2006 | US20060183712 Affinity purified heparin/heparan sulfate for controlling the biological activity of the FGF receptor |
| 08/17/2006 | US20060183711 Method and composition for treatment of a mucosal tissue disorder |
| 08/17/2006 | US20060183710 Chlamydia oligosaccharides |
| 08/17/2006 | US20060183709 Preparation of low molecular weight hyaluronic acid as a food supplement |
| 08/17/2006 | US20060183708 Topical Delivery of Trace Metals for Enzyme Modulation |
| 08/17/2006 | US20060183707 Production method of 2'-deoxyguanosine compound |
| 08/17/2006 | US20060183706 2-Beta-modified-6-substituted adenosine analogs and their use as antiviral agents |
| 08/17/2006 | US20060183699 Immunoglobins; antibodies; immunogens; hepatitis b surface antigens |
| 08/17/2006 | US20060183698 Ophthalmic formulations and uses thereof |
| 08/17/2006 | US20060183697 Complexing of medicinal substances with high-molecular carriers and injection and infusion solutions containing said complexes |
| 08/17/2006 | US20060183696 Use of immune cell specific conjugates for treatment of inflammatory diseases of gastrointestinal tract |
| 08/17/2006 | US20060183695 Methods of increasing endogenous erythropoietin (EPO) |
| 08/17/2006 | US20060183694 Serine protease inhibition via 1-{[1-(2-Methoxycarbonylamino-3,3-dimethyl-butyryl)-4-(7-methoxy-2-phenyl-quinolin-4-yloxy)-pyrrolidine-2-carbonyl]-amino}-2-vinyl-cyclopropanecarboxylic acid |
| 08/17/2006 | US20060183693 Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine |
| 08/17/2006 | US20060183692 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy |
| 08/17/2006 | US20060183685 Peptide pharmaceutical formulations |
| 08/17/2006 | US20060183684 For treating a disease or condition related to angiogenesis |
| 08/17/2006 | US20060183683 Liquid composition of factor VII polypeptides |
| 08/17/2006 | US20060183674 Compositions and methods for treating diabetes |
| 08/17/2006 | US20060183664 Pharmaceutical composition for delayed hypersensitivity |
| 08/17/2006 | US20060183225 producing antibodies by contacting chicken-derived B cells in which gene conversion occurs at an immunoglobulin locus with an amount of a histone deacetylase inhibitor effective for relaxing the chromatin structure of chromosomes |
| 08/17/2006 | US20060183192 Modulation of sodium channels in dorsal root ganglia |
| 08/17/2006 | US20060183191 Synthetic approach to designed chemical structures |
| 08/17/2006 | US20060183168 Method for optimizing therapeutic efficacy of nemorubicin |
| 08/17/2006 | US20060183116 Identifying an inhibitor of cysteine glucosaminyl inositol ligase; drug screening; for treatment of actinomycete infections in mammals using antibiotics that inhibit production or activity of the enzymes of mycothiol biosynthesis, in particular MshC, MshD or MshA |
| 08/17/2006 | US20060183105 Human brain-derived tissue-specific potassium channel |
| 08/17/2006 | US20060182828 Methods of reducing lipid peroxidation and achieving related health benefits by the administration of tocopherol and sesame lignans |
| 08/17/2006 | US20060182825 Methods and compounds for the treatment of obesity and obesity-related disorders |
| 08/17/2006 | US20060182824 Use of galactomannans as an active cosmetic agent |
| 08/17/2006 | US20060182821 Use of a plant extract |
| 08/17/2006 | US20060182819 Soap scent patch and treatment for muscle spasm and pain |
| 08/17/2006 | US20060182818 Transdermal patch and treatment for pain and discomfort |
| 08/17/2006 | US20060182817 Steroidal sapogenins and their derivatives for treating Alzheimer's disease |
| 08/17/2006 | US20060182814 Biochemically balanced peritoneal dialysis solutions |
| 08/17/2006 | US20060182810 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| 08/17/2006 | US20060182809 System for transporting active substances in a biological system |
| 08/17/2006 | US20060182808 Antisolvent solidification process |
| 08/17/2006 | US20060182805 Dosage form and method for sustained release of substituted pyrazine compound |
| 08/17/2006 | US20060182804 Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods |
| 08/17/2006 | US20060182802 Rapidly disintegrable solid preparation |
| 08/17/2006 | US20060182801 Sequestered antagonist formulations |
| 08/17/2006 | US20060182800 Novel pharmaceutical compositions for antihistaminic-decongestant combination and method of making such compositions |
| 08/17/2006 | US20060182797 Sutained release formulation for venlafaxine hydrochloride |
| 08/17/2006 | US20060182794 Stabilized compositions for topical administration and methods of making same |
| 08/17/2006 | US20060182791 Transdermaltherapeutic system containing a pramipexol active agent |
| 08/17/2006 | US20060182790 Dermal medicaments application enhancer |
| 08/17/2006 | US20060182784 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis |
| 08/17/2006 | US20060182778 Suture and graft delivery systems |
| 08/17/2006 | US20060182771 Formulations for ocular treatment |
| 08/17/2006 | US20060182764 Enhancing the effect of vaccines, particularly hepatitus B vaccines, by the use of ribavirin as an adjuvant; single administration |
| 08/17/2006 | US20060182761 Methionine salvage pathway in Bacillus |
| 08/17/2006 | US20060182753 Vaccines |
| 08/17/2006 | US20060182734 Contacting polysaccharide with disaccharide repeat unit of uronic acid [ alpha -L-iduronic acid or beta -D-glucuronic acid ] linked 1, 4 to alpha -D-hexosamine with mutant heparinase III; sequencing mucopolysaccharides; antitumor, anticarcinogenic and antimetastasis agents; angiogenesis inhibitors |
| 08/17/2006 | US20060182732 Composition for mitigating a pernicious thrombotic event |
| 08/17/2006 | US20060182731 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 08/17/2006 | US20060182729 Combat/training antioxidant micronutrient formulation and method of administration |
| 08/17/2006 | US20060182720 Cell preparation and use of the preparation for treating joints and cartilage defects, and methods for the production thereof |
| 08/17/2006 | US20060182718 Methods and compositions comprising DNA damaging agents and p53 |
| 08/17/2006 | US20060182710 Amphiphilic block copolymer and pharmaceutical formulation comprising the same |
| 08/17/2006 | US20060182692 Drugs covalently attached to a a hydrophilic polymer such as monomethoxy polyethylene glycol; pharmacokinetics; reduced first pass effect; side effect reduction; dosage forms; inhalers |
| 08/17/2006 | US20060182690 Alcoholic pump foam |
| 08/17/2006 | US20060182688 Metronidazole-based tinted topical pharmaceutical compositions |
| 08/17/2006 | US20060182686 kainate receptor agonists; immunoassay; measuring bioavailability, pharmacokinetics via onset of seizures |
| 08/17/2006 | US20060182683 Methods for reduced renal uptake of protein conjugates |
| 08/17/2006 | DE102005006241A1 Verwendung von Tryptophan, Nahrungsmittel und Getränk Use of tryptophan, food and drink |
| 08/17/2006 | DE10159120B4 Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung Steroid hormone-containing transdermal therapeutic systems containing Propylenglycolmonocaprylat and its use |
| 08/17/2006 | CA2604970A1 A tablet comprising a fibrate |
| 08/17/2006 | CA2599611A1 Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer |
| 08/17/2006 | CA2599112A1 Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient |
| 08/17/2006 | CA2597798A1 Fluorinated phno and analogs thereof |
| 08/17/2006 | CA2597748A1 Non steroidal glucocorticoid receptor modulators |
| 08/17/2006 | CA2597640A1 Cosmetic and cosmeceutical compositions for restoration of skin barrier function |
| 08/17/2006 | CA2597608A1 Pyrazolo-pyrimidine derivatives as mglur2 antagonists |
| 08/17/2006 | CA2597596A1 Liquid formulations of rapamycin for intraocular delivery |
| 08/17/2006 | CA2597595A1 Substituted fused [1,2]imidazo[4,5-c] ring compounds and methods |
| 08/17/2006 | CA2597590A1 Formulations for ocular treatment |
| 08/17/2006 | CA2597587A1 Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods |
| 08/17/2006 | CA2597574A1 Substituted hydroxyethylamines |
| 08/17/2006 | CA2597568A1 2-methylene-19-nor-(20s-24epi)-1.alpha.,25-dihydroxyvitamin-d2 |
| 08/17/2006 | CA2597566A1 Treating microvasculature diseases with acetyl cholinesterase inhibitors |